Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2011 - 2015)
Vanda Pharmaceuticals (VNDA) reported Other Non-Current Assets of $813000.0 for Q3 2015, up 3.57% on a YoY basis from $785000.0 in Q3 2014, and little changed sequentially from $813000.0 in Q2 2015.
Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2011 - 2015) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 5 years of Other Non-Current Assets data on file, last reported at $813000.0 in Q3 2015.
- For the quarter ending Q3 2015, Other Non-Current Assets rose 3.57% year-over-year to $813000.0; the trailing twelve-month figure through Sep 2015 stood at $813000.0 (up 3.57% YoY), and the FY2014 full-year result was $813000.0, up 62.6% from the prior year.
- Other Non-Current Assets held at $813000.0 in Q3 2015, from $813000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q3 2011 to a low of $84000.0 in Q1 2012.
- A 5-year average of $682277.8 and a median of $692500.0 in 2011 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 41.75% in 2012 and jumped 614.29% in 2013, its largest moves.
- Tracing VNDA's Other Non-Current Assets over 5 years: stood at $600000.0 in 2011, then changed by 0.0% to $600000.0 in 2012, then slipped by 16.67% to $500000.0 in 2013, then soared by 62.6% to $813000.0 in 2014, then changed by 0.0% to $813000.0 in 2015.
- Business Quant data shows VNDA's Other Non-Current Assets at $813000.0 in Q3 2015, $813000.0 in Q2 2015, and $813000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 813,000.00 |
| Jun 30, 2015 | 813,000.00 |
| Mar 31, 2015 | 813,000.00 |
| Dec 31, 2014 | 813,000.00 |
| Sep 30, 2014 | 785,000.00 |
| Jun 30, 2014 | 785,000.00 |
| Mar 31, 2014 | 785,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Sep 30, 2013 | 500,000.00 |
| Jun 30, 2013 | 600,000.00 |
| Mar 31, 2013 | 600,000.00 |
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 600,000.00 |
| Jun 30, 2012 | 1.03 Mn |
| Mar 31, 2012 | 84,000.00 |
| Dec 31, 2011 | 600,000.00 |
| Sep 30, 2011 | 1.03 Mn |
| Jun 30, 2011 | 530,000.00 |